Sambratha Shetty
Chief Operating Officer, Synergia Foundation
A clear picture of India’s drug discovery
India’s domestic pharmaceutical industry excels in the production of generic medicines but the rate of drug discovery is staggeringly below the global industry average. Drug discovery is an expensive, slow and risky business and most Indian companies do not have sufficient financial resources to take the risk to develop a new drug from scratch. Does India have the resources to become the pharmaceutical powerhouse, it aspires to be?
To read the full research paper, Subscribe.
Hon Sec Michael Chertoff
Fmr Sec U.S. Homeland Security
Decline of the Grand Strategy
Nirupama Rao
Former Foreign Secretary, GOI
Reflections on India’s Foreign Policy
Melissa Hathaway
President, Hathaway Global Strategies
Securing Critical Infrastructure
Dr. A.J. Paulraj
Marconi Prize, Stanford University
Information Technology Express
Joseph S. Nye
Fmr Dean, Kennedy School at Harvard Uty
The Myth Of A New World Order
